Back to search results

Comparing Robotic vs. Laparoscopic Sleeve Gastrectomy for Obesity

This study is comparing two types of weight-loss surgery for people with obesity: Laparoscopic Sleeve Gastrectomy (LSG) and Robotic Sleeve Gastrectomy (RSG). Researchers want to see if one surgery leads to less pain after the operation. They will measure the amount of pain medication (morphine equivalent dose) you need 24 hours after surgery. You might be able to join if you are between 18 and 70 years old, eligible for sleeve gastrectomy based on NIH guidelines, can give consent, are medically cleared for surgery, and can tolerate general anesthesia. This study will take place at the Cleveland Clinic Bariatric and Metabolic Institute.

Study design
This is a randomized controlled trial, meaning participants will be randomly assigned to receive either LSG or RSG. About 91 people are expected to participate.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The primary outcome is measured 24 hours after surgery.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06425016

Effects of Assisted Robotic vs Laparoscopic Sleeve Gastrectomy

Recruiting
NAAges 18–70InterventionalSupportive care
Ricard Corcelles
~91 participants
Updated 2025-12-10 on ClinicalTrials.gov
What's tested:Laparoscopic Sleeve Gastrectomy (LSG)Robotic Sleeve Gastrectomy (RSG)

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Comparing post-operative day-1 morphine equivalent dose consumption (mg)
Measured over 24 hours post-op

Conditions

Post Operative Pain
Laparoscopic Sleeve Gastrectomy
Robotic Sleeve Gastrectomy
Obesity
Bariatric Surgery Candidate
Quality of Life

Explore related trials

Obesity

Where it's being run

1 sites across 1 states
Ohio1

Study leadership

  • Ricard Corcelles Codina, MD · PRINCIPAL_INVESTIGATOR · The Cleveland Clinic

Who to contact

Ricard Corcelles Codina, MD
[email protected]
216-445-2665
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

All patients eligible to undergo a SG based on the current National Institute of Health (NIH) patient selection guidelines. Patients should be able to give consent, be deemed medically cleared to undergo elective surgery, and tolerate general anesthesia.

Exclusion

patients with previous bariatric surgeries, emergency surgeries, with chronic opioid use (daily use of opioids for at least 3 months), and those who are not able to sign the written consent form.

What this trial measures

  • Comparing post-operative day-1 morphine equivalent dose consumption (mg)24 hours post-op

    To determine if patients with obesity planned for robotic sleeve gastrectomy experience a decrease in opioid consumption (Morphine Equivalent Dose) in mg on postoperative day 1 compared to patients undergoing laparoscopic sleeve gastrectomy.